IMAX - IMAX Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMAX in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" IMAX shares.
View IMAX analyst ratings or view top-rated stocks.

7 brokers have issued twelve-month price objectives for IMAX's shares. Their IMAX share price forecasts range from $16.00 to $23.00. On average, they anticipate the company's stock price to reach $20.43 in the next twelve months. This suggests a possible upside of 15.5% from the stock's current price.
View analysts price targets for IMAX or view top-rated stocks among Wall Street analysts.

IMAX's stock was trading at $14.66 at the start of the year. Since then, IMAX shares have increased by 20.6% and is now trading at $17.68.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our IMAX earnings forecast.

IMAX Co. (NYSE:IMAX) posted its earnings results on Thursday, October, 28th. The company reported ($0.08) EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.14. The firm had revenue of $56.60 million for the quarter, compared to analyst estimates of $56.73 million. IMAX had a negative trailing twelve-month return on equity of 2.98% and a negative net margin of 4.92%. The firm's revenue for the quarter was up 51.9% compared to the same quarter last year. During the same quarter last year, the company earned ($0.84) EPS.

36 employees have rated IMAX Chief Executive Officer Richard L. Gelfond on Glassdoor.com. Richard L. Gelfond has an approval rating of 63% among the company's employees. This puts Richard L. Gelfond in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other IMAX investors own include Stillwater Mining (SWC), Integrated Device Technology (IDTI), Turquoise Hill Resources (TRQ), Skyworks Solutions (SWKS), Progenics Pharmaceuticals (PGNX), InvenSense (INVN), Walt Disney (DIS), Intel (INTC), Tesla (TSLA) and Gilead Sciences (GILD).

IMAX trades on the New York Stock Exchange (NYSE) under the ticker symbol "IMAX."

IMAX's stock is owned by many different retail and institutional investors. Top institutional shareholders include Peregrine Capital Management LLC (1.08%), Foundry Partners LLC (0.59%), Mizuho Markets Americas LLC (0.52%), Wolverine Asset Management LLC (0.00%), Laurus Investment Counsel Inc. (0.21%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Denny Tu, Giovanni M Dolci, Jacqueline Bassani, Kenneth Ian Weissman, Mark Welton, Megan Colligan, Patrick Mcclymont, Richard L Gelfond and Robert D Lister.
View institutional ownership trends.

Shares of IMAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of IMAX stock can currently be purchased for approximately $17.68.

IMAX (NYSE:IMAX) has a market capitalization of $989.55 million and generates $254.88 million in revenue each year. The company earns $-22,330,000.00 in net income (profit) each year or ($0.27) on an earnings per share basis.

The company employs 665 workers across the globe.

IMAX's mailing address is 2525 Speakman Drive, Mississauga A6, L5K 1B1. The official website for the company is www.imax.com. The company can be reached via phone at (905) 403-6500, via email at investorrelations@imax.com, or via fax at 905-403-6408.